Immediate Impact
50 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
Works of Jennifer Smit being referenced
Phase I study of teclistamab, a humanized B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in relapsed/refractory multiple myeloma (R/R MM).
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jennifer Smit | 928 | 504 | 394 | 89 | 1.4k | |
| Justine Bukenya | 515 | 449 | 259 | 55 | 1.2k | |
| Stella Neema | 967 | 776 | 591 | 67 | 2.0k | |
| Phillip Nieburg | 705 | 476 | 392 | 49 | 2.1k | |
| Manjulaa Narasimhan | 775 | 600 | 329 | 95 | 2.0k | |
| Joseph Konde-Lule | 947 | 1118 | 212 | 58 | 2.0k | |
| L. M. Williamson | 617 | 376 | 295 | 50 | 2.1k | |
| Rebecca French | 657 | 433 | 477 | 80 | 1.8k | |
| Malcolm Potts | 643 | 316 | 589 | 112 | 2.1k | |
| Anette Agardh | 849 | 444 | 346 | 100 | 1.8k | |
| Loretta Gavin | 1009 | 250 | 811 | 42 | 2.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...